Considerations on Thrombotic Events Following Administration of the OXford-AstraZeneca COVID-19 Vaccine in Europe, 7 April 2021
MetadataShow full item record
The Pan American Health Organization (PAHO) has issued this communiqué in response to the information circulating about potential risks associated with use of the COVID-19 vaccine developed by AstraZeneca and Oxford University, considering the reports of events in European countries. This communiqué offers an overview of the adverse effects following the administration of the Oxford–AstraZeneca COVID-19 vaccine notified in Europe, and of the recommendations issued by the World Health Organization, the European Medicines Agency, and other national regulatory authorities in that respect. In addition, it includes the recommendations of the Pan American Health Organization in consideration of the information and the evidence available.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Surveillance of adverse events associated with 145 000 doses of COVID-19 vaccines in a Brazilian municipality Martins-Filho, Paulo Ricardo; Santana, Ricardo Ruan Rocha; Cavalcante, Taise Ferreira; Barboza, Waneska de Souza; Góes, Marco Aurelio de Oliveira; Fontes, Ângela Marinho Barreto; Silva, Marcia Estela Lopes da; Tanajura, Diego Moura (2022-08-11)[ABSTRACT]. There is a lack of real-world surveillance studies on reports of adverse events associated with COVID-19 vaccination, as well as comparative analyses of adverse events from vaccines with different platforms. ...
SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil Rodrigues Campos, Karoline; Tavares Sacchi, Cláudio; Abbud, Adriano; Caterino-de-Araujo, Adele (2021-09-15)[ABSTRACT]. COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca ...
Taborda R., Alejandra; Murillo, Diego Alejandro; Moreno L., Carolina; Taborda R., Paula Andrea; Fuquen, Marcela; Díaz, Paula Andrea; Londoño, Darío (2022-01-11)[RESUMEN]. Objetivo. Estimar el impacto presupuestal de la vacunación contra COVID-19 en seis países de América Latina: Argentina, Brasil, Chile, Colombia, México y Perú, durante el periodo 2021-2022. Métodos. Se evaluaron ...